Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug
Briefly

Sen. Bernie Sanders highlighted the dire consequences of high drug prices, stating, 'What these doctors are telling us is if the price of Ozempic and Wegovy is not reduced, many of their patients who have diabetes and obesity, especially lower-income Americans often minority Americans, will not be able to afford these drugs.' He emphasized that the unaffordable price could lead to unnecessary deaths and a decline in quality of life for vulnerable patients.
Lars Jorgensen responded to concerns by discussing the challenges posed by the U.S. health care system, asserting, 'The complex U.S. health care system. It's also clear that no single company alone can solve such complicated policy changes.' He promised engagement with policy solutions but emphasized the systemic issues that need addressing.
Read at ABC7 San Francisco
[
]
[
|
]